Pharmacy Industry Updates: May 2020

Every month, our Industry Relations Director, Leann Lewis provides an in-depth industry update to customers. Below, you will find an agenda for the industry update for May. If you have any questions regarding any of the points, contact us here.

PDMP Updates

Florida

• New Data Submission Guide Published late March, version 2.4
• Updates on Zero reports and Pickup/Dropoff qualifier.

Washington

• Moving from the Appriss Legacy RxSentry to Appriss PMP AWARxE Platform on 04-21-2020
• Registration begins on 03-25-2020
• Data Submission Guide ASAP Version 4.2A

Utah – Will be moving to NIC’s RxGov in the future

• 04-02-2020– Utah still in holding pattern with RxGov
• Last Estimate was mid-April

 California 

• 01-01-2021 Require reporting ”as soon as reasonably possible but no more than one working day after acontrolled substance is dispensed.”

• Also requires Schedule V  reporting

Nebraska

• Possible move to “near real time” as a pilot later this year
• Require a valid Date Sold (DSP17)
• Waiting on legislative action but will be emergency legislation
• Grant money is available for POS integration and real time

Kentucky and Oklahoma

• Move to ASAP 4.2B by Jan 2021.  Waiting for additional details.

PDMP Checking prior to dispensing

• Illinois – required integration by 01-01-2021
• Nebraska – considering requirement by 01-01-2021

Legislative/Regulatory Reminders for May 2020

• Alabama – Updates rules related to hazardous waste pharmaceuticals
• Iowa – Updates to the Technician Verification Program
• Licensing, certification, continuing education rule in many states including:
  • Missouri, Utah, West Virginia
• West Virginia – Centralized Prescription Processing

New Legislative/Regulatory Highlights

• EPCS – Utah requires as of 01-01-2022
• Insulin Cost Share – Limits the cost share on a 30-day supply from $35- $100
  • Maine, Utah, Virginia, Washington, West Virginia
• Strengthened PBM and Medicaid Reimbursement, Network, and Recoupment
  • Colorado, Indiana, Kentucky, Maine, Virginia, Washington

Get Involved/Get Informed Spotlight

COVID – 19 Resources and Items of Interest

• NASPA – National Alliance of State Pharmacy Associations
  • https://naspa.us/resource/covid-19-information-from-the-states/

• NAPB Summary of COVID -19 Emergency Rules/Waivers by State
  • https://nabp.pharmacy/wp-content/uploads/2020/03/COVID-19-Board-of-Pharmacy-Status.pdf

• HHS Guidance for Licensed Pharmacists, COVID-19 Testing under the PREP Act
  • https://www.hhs.gov/about/news/2020/04/08/hhs-statements-on-authorizing-licensed- pharmacists-to-order-and-administer-covid-19-tests.html
  • https://www.hhs.gov/sites/default/files/authorizing-licensed-pharmacists-to-order-and- administer-covid-19-tests.pdf

• Clinical Laboratory Improvement Amendments (CLIA) Waiver Form and Instructions
  • https://www.cms.gov/Medicare/CMS-Forms/CMS-Forms/downloads/cms116.pdf
  • https://www.cms.gov/Regulations-and- Guidance/Legislation/CLIA/downloads/HowObtainCertificateofWaiver.pdf

• NCPA Resource page with webinars
  • https://ncpa.org/coronavirus-information

• NACDS – National Association of Chain Drug Stores
  • https://www.nacds.org/prepared/

• NCPDP – National Council for Prescription Drug Programs
  • https://ncpdp.org/Resources/Emergency-Preparedness

• Healthcare Ready / RX Open is “Engaged” http://rxopen.org/

Quantity Prescribed (CMS-0055-F) Compliance Date 09-21-2020

Rutledge vs. PCMA Update Tentatively rescheduled for October session

Contact us to ask questions or get more information about these updates.

Disclaimer:

The organizer of this call is not an attorney, and the presentation on this call does not constitute legal advice.  It contains only the opinions and observations of the organizer and its participants.  Any use of information contained in this presentation is at the user’s own risk. The organizer will not be available for depositions or testimony in case of litigation.